Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies
- Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing
- £50m to be invested by Novo Holdings as part of an equity issue
- Novo Holdings intends to make further share purchases over time in the secondary market, subject to availability and price (among other factors)
COPENHAGEN, DENMARK — Novo Holdings, a leading international life science investor, today announced a £50m investment in Oxford Nanopore Technologies (‘Oxford Nanopore’/‘the Company’), the leading UK Listed company behind a new generation of molecular sensing technology based on nanopores.
